Albany, NY -- (SBWIRE) -- 12/28/2015 -- A new research report, titled "Epinephrine Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019", from Transparency Market Research offers a 360-degree view of the market. The global market for epinephrine is projected to witness significant growth in the coming few years. The study analyzes the various key drivers that will impact the growth of the global epinephrine market in the coming few years.

Adrenaline or epinephrine is a hormone secreted by the adrenal glands into the bloodstream. Adrenaline is one of the two common hormones responsible for glycogen breakdown. Epinephrine injections are used generally to counter life-threatening allergic reactions caused by insect bites or stings and medications. These injections are available as pre-filled automatic injection devices with the hormone present in them in the liquid form. The directions to prepare and use epinephrine injectors depends on the type of brand. They are usually administered on the thighs and the effect of this medicine is fast, but not long lasting. Epinephrine can cause both mild and serious side effects such as chest pain, high blood pressure, and blurred vision.

Browse Full Report: http://www.transparencymarketresearch.com/epinephrine-market.html

The global epinephrine market is driven by the rising patient population that is susceptible to various allergic reactions. In addition to this, growing focus of market players on developing epinephrine auto-injectors free from chlorofluorocarbon (CFC). This growing focus is primarily due to the ban imposed by the U.S. government on the use of CFC as a propellant inhaler.

The global epinephrine market will also benefit greatly from the continuous product modification and growing demand for automatic injection devices. The market for epinephrine auto-injectors is projected to experience tremendous growth due to the growing focus on the development of innovative epinephrine injectors. The two types of epinephrine auto-injectors available in the global epinephrine market are EpiPen and Anapen. These are classified as S3 drugs and can be bought from a pharmacy without a prescription.

Get Free Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2466

Injections administered by a non-medical person pose many risks and challenges. On the other hand, an auto-injector can help clinical professionals and users by reducing anxiety and offering the ease of self-administering the drug. The improved safety associated with epinephrine auto-injectors will substantially drive the overall epinephrine market.

Although the global epinephrine market will be driven by the aforesaid factors, the adverse side effects associated with the excessive usage of epinephrine will suppress the market. Some of the side effects associated with excessive use of epinephrine are vomiting, pulmonary edema, cardiac arrhythmia, and cerebral hemorrhage.

Some of the key players operating in the global epinephrine market are Adamis Pharmaceuticals, Teva Pharmaceuticals, Hospira, and Amedra Pharmaceuticals.

About Transparency Market Research
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR's global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:
Mr. Sudip S
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: 518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/